1. Aisanov Z., Avdeev S., Arkhipov V. et al. Russian experience of creating clinical COPD guidelines and a clinical decision making algorithm. Int. J. COPD. 2018; 13: 183-187.
2. Lozano R., Naghavi M., Foreman K. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2095-2128. https://doi.org/10.1016/S0140-6736(12)61728-0.
3. Eisner M.D., Anthonisen N., Coultas D. et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010; 182 (5): 693-718. https://doi.org/10.1164/rccm.200811-1757ST.
4. Rosenberg S.R., Kalhan R., Mannino D.M. Epidemiology of chronic obstructive pulmonary disease: prevalence, morbidity, mortality, and risk factors. Semin. Respir. Crit. Care Med. 2015; 36 (4): 457-469. https://doi.org/10.1055/s-0035-1555607.
5. Buist A.S., McBurnie M.A., Vollmer W.M. et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007; 370 (9589):741-750. https://doi.org/10.1016/S0140-6736(07)61377-4.
6. Menezes A.M., Perez-Padilla R., Jardim J.R. et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005; 366 (9500): 1875-1881. https://doi.org/10.1016/S0140-6736(05)67632-5.
7. Soriano J.B., Ancochea J., Miravitlles M. et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997 - 2007. Eur. Respir. J. 2010; 36 (4): 758-765. https://doi.org/10.1183/09031936.00138409.
8. Duong M., Islam S., Rangarajan S. et al. Global differences in lung function by region (PURE): an international, community-based prospective study. Lancet Respira. Med. 2013; 1 (8): 599-609. https://doi.org/10.1016/S2213-2600(13)70164-4.
9. Chuchalin A.G., Khaltaev N., Antonov N.S. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 963-974. https://doi.org/10.2147/COPD.S67283.
10. Artyukhov I.P., Arshukova I.L., Dobretsova E.A. et al. Epidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region, Russia. Int. J. Chron. Obstruct. Pulmon. Dis. 2015; 10: 1781-1786. https://doi.org/10.2147/COPD.S79601.
11. Ciapponi A., Alison L., Agustina M. et al. The epidemiology and burden of COPD in Latin America and the Caribbean: systematic review and meta-analysis. COPD. 2014; 11 (3): 339-350. https://doi.org/10.3109/15412555.2013.836479.
12. Siafakas N.M., Vermeire P., Pride N.B. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur. Respir. J. 1995; 8 (8): 1398-1420.
13. Fletcher C., Peto R. The natural history of chronic airfl¬ow obstruction. Br. Med. J. 1977; 1: 1645e8.
14. Suissa S., Dell’Aniello S., Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012; 67 (11): 957-963. https://doi.org/10.1136/thoraxjnl-2011-201518.
15. Soler-Cataluna J., Martinez-Garcia M., Roman S. et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005; 60 (11): 925-931. https://doi.org/10.1136/thx.2005.040527.
16. Hoogendoorn M., Hoogenveen R.T., Rutten-van Mölken M.P. et al. Case fatality of COPD exacerbations: a meta-analysis and statistical modeling approach. Eur. Respir. J. 2011; 37 (3): 508-515. https://doi.org/10.1183/ 09031936.00043710.
17. Hansell A.L., Walk J.A., Soriano J.B. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur. Respir. J. 2003; 22 (5): 809-814. https://doi.org/10.1183/09031936.03.00031403.
18. Mannino D.M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur. Respir. J. 2008; 32 (4): 962-969. https://doi.org/10.1183/09031936.00012408.
19. Nie J.X., Wang L., Upshur R.E. Mortality of elderly patients in Ontario after hospital admission for chronic obstructive pulmonary disease. Can. Respir. J. 2007; 14 (8): 485-489.
20. Celli B.R. Predictors of mortality in COPD. Respir. Med. 2009; 104 (6): 773-779. https://doi.org/10.1016/j.rmed.2009.12.017.
21. Puhan M.A., Garcia-Aymerich J., Frey M. et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009; 374 (9691): 704-71. https://doi.org/10.1016/S0140-6736(09)61301-5.
22. Jones R.C., Donaldson G.C., Chavannes N.H. et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am. J. Respir. Crit. Care Med. 2009; 180 (12): 1189-1195. https://doi.org/10.1164/rccm.200902-0271OC.
23. Steer J., Gibson J., Bourke S.C. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012; 67: 970-976. https://doi.org/10.1136/thoraxjnl-2012-202103.
24. Casanova C., Cote C., de Torres J.P. et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 171: 591-597. https://doi.org/10.1164/rccm.200407-867OC.
25. Brulotte C.A., Lang E.S. Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Emergency Department. Emerg. Med. Clin. N. Am. 2012; 30 (2): 223-247. https://doi.org/10.1016/j.emc.2011.10.005.
26. Hurst J.R., Vestbo J., Anzueto A. et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 2010; 363: 1128-38. https://doi.org/10.1056/NEJMoa0909883.
27. MacDonald M., Beasley R.W., Irving L. et al. A hypothesis to phenotype COPD exacerbations by aetiology. Respirology. 2011; 16: 264-268. https://doi.org/10.1111/j.1440-1843.2010.01908.x.
28. Bafadhel M., McKenna S., Terry S. et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am. J. Respir. Crit. Care Med. 2011; 184: 662-671. https://doi.org/10.1164/rccm.201104-0597OC.
29. Anthonisen N.R., Manfreda J., Warren C.P. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106: 196-204. https://doi.org/10.7326/0003-4819-106-2-196.
30. Martinez F.J., Foster G., Curtis J.L. et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am. J. Respir. Crit. Care Med. 2006; 173 (12): 1326-1334. https://doi.org/10.1164/rccm.200510-1677OC.
31. Brill S.E., Wedzicha J.A. Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 1241-1252. https://doi.org/10.2147/COPD.S41476.
32. Roberts C.M., Stone R.A., Buckingham R.J. et al. Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax. 2011; 66 (1): 43-48. https://doi.org/10.1136/thx.2010.153114.
33. Wedzicha J.A., Singh R., Mackay A.J. Acute COPD exacerbations. Clin. Chest Med. 2014; 35 (1): 157-163. https://doi.org/10.1016/j.ccm.2013.11.001.
34. Barberà J.A., Roca J., Ferrer A. et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur. Respir. J. 1997; 10 (6): 1285-1291.
35. O'Driscoll B.R., Howard L.S., Earis J. et al. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017; 72 (Suppl. 1): ii1-ii90. https://doi.org/10.1136/thoraxjnl-2016-209729.
36. Roberts C.M., Stone R.A., Buckingham R.J. et al. Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax. 2011; 66: 43-48. https://doi.org/10.1136/thx.2010.153114.
37. Köhnlein T., Windisch W., Köhler D. et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomized, controlled clinical trial. Lancet Respir. Med. 2014; 2 (9): 698-705. https://doi.org/10.1016/S2213-2600(14)70153-5.
38. Windisch W. Impact of home mechanical ventilation on health-related quality of life. Eur. Respir. J. 2008; 32: 1328-1336. https://doi.org/10.1183/09031936.00066407